Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125097032 | 12509703 | 2 | F | 20140605 | 20160706 | 20160629 | 20160719 | EXP | TW-ACTAVIS-2016-13884 | ACTAVIS | CHONG CH, LAI GM, LIN JT. CENTRAL PONTINE MYELINOLYSIS (CPM) AND EXTRAPONTINE MYELINOLYSIS (EPM) FOLLOWING CONCURRENT CHEMORADIOTHERAPY FOR NASOPHARYNGEAL CARCINOMA. JOURNAL OF CANCER RESEARCH AND PRACTICE. 2016;3(2):58-62. | 50.00 | YR | F | Y | 0.00000 | 20160719 | MD | TW | TW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125097032 | 12509703 | 1 | SS | Cisplatin (Unknown) | CISPLATIN | 1 | Unknown | 80 MG/M2, DAILY - SINGLE 6-HR INFUSION | UNCONFIRMED | 0 | 80 | MG/M**2 | UNK | QD | |||||
| 125097032 | 12509703 | 2 | PS | Docetaxel (Unknown) | DOCETAXEL | 1 | Unknown | 60 MG/M2, DAILY - SINGLE 1-HR INFUSION | UNCONFIRMED | 203551 | 60 | MG/M**2 | UNK | QD | |||||
| 125097032 | 12509703 | 3 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | 800 MG/M2, UNK - DAY 1 TO 4 - CONTINUOUS PUMP | 0 | 800 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125097032 | 12509703 | 1 | Nasopharyngeal cancer recurrent |
| 125097032 | 12509703 | 2 | Nasopharyngeal cancer recurrent |
| 125097032 | 12509703 | 3 | Nasopharyngeal cancer recurrent |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125097032 | 12509703 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125097032 | 12509703 | Febrile neutropenia | |
| 125097032 | 12509703 | Hyponatraemia | |
| 125097032 | 12509703 | Osmotic demyelination syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |